Evidence map›Paper›PMID 32231810›Full record

ArticleCase reports in dentistry2020

Management of OSAS: The ELIBA® Device Can Help the Patient?

Eleonora Ortu, Davide Pietropaoli, Alessandra Mummolo, Iapnor, Mario Giannoni, Annalisa Monaco

Abstract readCase Reports
In one paragraph

Article in Case reports in dentistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Prevalence of Obstructive Sleep Apnea Syndrome: A Single-Center Retrospective Study.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eleonora OrtuMeSVA Department, Division of Dentistry, University of L'Aquila, P.le Salvatore Tommasi, 67100 L'Aquila, Italy.ORCID https://orcid.org/0000-0002-9550-2155
Davide PietropaoliMeSVA Department, Division of Dentistry, University of L'Aquila, P.le Salvatore Tommasi, 67100 L'Aquila, Italy.ORCID https://orcid.org/0000-0001-9585-1809
Alessandra MummoloMeSVA Department, Division of Dentistry, University of L'Aquila, P.le Salvatore Tommasi, 67100 L'Aquila, Italy.ORCID https://orcid.org/0000-0002-9696-3009
IapnorI. A.P.N.O.R.-International Academy of Posture and Neuromyofascial Occlusion Research, Viale Gino Moretti 37, 63074 San Benedetto del Tronto, AP, Italy.
Mario GiannoniMeSVA Department, Division of Dentistry, University of L'Aquila, P.le Salvatore Tommasi, 67100 L'Aquila, Italy.
Annalisa MonacoMeSVA Department, Division of Dentistry, University of L'Aquila, P.le Salvatore Tommasi, 67100 L'Aquila, Italy.ORCID https://orcid.org/0000-0002-9567-4459

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obstructive sleep apnea syndrome (OSAS) is one of the most challenging diseases to treat in medicine. Here, the authors describe a case of OSAS treated with a lingual elevator of Balercia (ELIBA®). The patient, a forty-five-year-old Caucasian male, had a chief complaint of numerous episodes of nocturnal apnea. After several visits with specialists, a polysomnographic examination was performed, in which the patient's apnea hypopnea index (AHI) was 30.4, and a lingual elevator was prescribed. The lingual elevator helped to keep the patient's tongue in the correct position and prevented the tongue from reverting back to the soft tissue spaces in the mouth. After six months of treatment with the lingual elevator and dietary adjustments, the patient's AHI decreased to 11.6. This simple yet customizable approach is a comfortable and easy option for patients to reduce night apnea episodes.

Identifiers

PMID32231810
PMCPMC7085363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.